Ametris
1 known investors
Ametris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.
Founders & leadership
JW
Jeremy WyattinFounder
Investors · 1
In the news
Frequently asked questions
- What does Ametris do?
- Ametris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.
- Who are Ametris's investors?
- Ametris's investors include ARCHIMED Japan.